Archives

by in
Entry Author Date Location
Wisconsin Roundup: Gener8tor, Epic, Lucigen, 3D Printing, & More 03/18/15 Wisconsin
Lucigen Grabs $2M to Move Rapid Ebola, C. Diff Diagnostics to Market 01/15/15 Wisconsin
With Crossover Cash, Seres Health Aims For Big Microbiome Milestones 12/02/14 Boston
Ebola Outbreak a Proving Ground for Lucigen’s Rapid Diagnostic 11/03/14 Wisconsin
Microbiome Startup Seres Health Tabs Pharma Vet Pomerantz as CEO 06/02/14 Boston
Lucigen Takes On Diagnostic Giants With On-the-Spot Pathogen Tests 01/30/14 Wisconsin
Optimer Inks Potential $47.5M-Plus Deal with Cubist to Help Sell Antibiotic 04/06/11 San Diego
Optimer Seeks Quick Green Light From FDA for Antibiotic Against Deadly Bug 11/30/10 San Diego
Optimer Halts Study After Antibiotic for Traveler’s Diarrhea Linked to Rash; Shares Drop 11/10/10 San Diego
Indel Therapeutics Aims High With New Class of Antibiotics to Fight Hospital Infections 03/30/09 Seattle
Vioguard CEO Larry Ranta Takes Germ-Zapping Keyboard Into Growing Hospital Market 03/26/09 Seattle
Optimer Raises $32.9M in Stock Offering 03/05/09 San Diego
Optimer’s Second Drug, for Traveler’s Diarrhea, Follows Fast Behind Lead “C. Diff” Antibiotic 01/23/09 San Diego
Optimer Sharpens Up Commercial Game Plan, After “C.Diff” Drug Success 12/05/08 San Diego
Navilyst Medical, Boston Scientific Spin-Off, Aiming to Tap Veins Without Causing Infections 08/05/08 Boston
Page 1 of 1